Functional Analysis of PS1 Interacting Protein PSIP1
About the Research Project
Program
Award Type
Standard
Award Amount
$98,445
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005319
Summary
Over the past decade, molecular geneticists have identified genes that are mutated in families with early-onset forms of AD. These genes encode presenilin 1 (PS1), presenilin 2 (PS2), and APP. G-secretase is a large macromolecular complex that consists of presenilin and several additional proteins. The focus of Dr. Zhang’s project is to examine the cell biology of another protein, termed PSIP1, an evolutionary conserved molecule with no known function. Dr. Zhang has confirmed the association of PSIP1 and PS1 in stable cell lines, and has developed highly specific anti-PSIP1 antibodies to examine the subcellular distribution and trafficking of this protein. Understanding of the molecular mechanism(s) by which PSIP1 modulates g-secretase processing may offer new insights into potential targets for therapeutic intervention in AD.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University